Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Debruyne

Showing results (101-110 of 116) with videos related to

Pageof 12
Sort By:
Progress in Clinical and Biological Research|January 1, 1986
Experimental models of bladder cancer: a critical reviewD Raghavan, F Debruyne, H Herr, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 1, 1995
Basic researchF Debruyne, O Yoshida, C Olsson, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1987
BCG-RIVM: a new BCG preparation for intravesical immunotherapy of superficial bladder cancerL Schreinemachers, A Van der Meyden, P Steerenberg, et al.
The Journal of Urology|May 1, 1996
Clinical diagnosis of bladder outlet obstruction in patients with benign prostatic enlargement and lower urinary tract symptoms: development and urodynamic validation of a clinical prostate score for the objective diagnosis of bladder outlet obstructionP F Rosier, M J de Wildt, H Wijkstra, et al.
Progress in Clinical and Biological Research|January 1, 1990
The value of the bone scanP H Smith, F Debruyne, T G Armitage, et al.
Actas Urologicas Espanolas|June 14, 2001
[The future of urology in Europe: a perspective from the European Urology Association]R Vela Navarrete, J T Andersen, A Borowka, et al.
Progress in Clinical and Biological Research|January 1, 1989
Long-term follow-up in superficial transitional cell carcinoma of the bladder: prognostic factors for time to first recurrence, recurrence rate, and survival. Final results of a randomized trial comparing doxorubicin hydrochloride, ethoglucid, and transurethral resection alone. EORTC Genitourinary Tract Cancer Cooperative GroupK Kurth, F H Schroeder, F Debruyne, et al.
European Urology|April 18, 2001
The future of urology in Europe: an overview from the European association of urologyR Vela Navarrete, J T Andersen, A Borowka, et al.
B-ENT|February 10, 2011
Antibiotic use and doctor visits are reduced after adenotonsillectomyN Lemkens, P Lemkens, T W Egondi, et al.
Cancer|September 1, 1990
Some limitations of the radioisotope bone scan in patients with metastatic prostatic cancer. A subanalysis of EORTC trial 30853. The EORTC Urological GroupP H Smith, A Bono, F Calais da Silva, et al.
Pageof 12

Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Progress in Clinical and Biological Research|January 1, 1986
Experimental models of bladder cancer: a critical reviewD Raghavan, F Debruyne, H Herr, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 1, 1995
Basic researchF Debruyne, O Yoshida, C Olsson, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1987
BCG-RIVM: a new BCG preparation for intravesical immunotherapy of superficial bladder cancerL Schreinemachers, A Van der Meyden, P Steerenberg, et al.
The Journal of Urology|May 1, 1996
Clinical diagnosis of bladder outlet obstruction in patients with benign prostatic enlargement and lower urinary tract symptoms: development and urodynamic validation of a clinical prostate score for the objective diagnosis of bladder outlet obstructionP F Rosier, M J de Wildt, H Wijkstra, et al.
Progress in Clinical and Biological Research|January 1, 1990
The value of the bone scanP H Smith, F Debruyne, T G Armitage, et al.
Actas Urologicas Espanolas|June 14, 2001
[The future of urology in Europe: a perspective from the European Urology Association]R Vela Navarrete, J T Andersen, A Borowka, et al.
Progress in Clinical and Biological Research|January 1, 1989
Long-term follow-up in superficial transitional cell carcinoma of the bladder: prognostic factors for time to first recurrence, recurrence rate, and survival. Final results of a randomized trial comparing doxorubicin hydrochloride, ethoglucid, and transurethral resection alone. EORTC Genitourinary Tract Cancer Cooperative GroupK Kurth, F H Schroeder, F Debruyne, et al.
European Urology|April 18, 2001
The future of urology in Europe: an overview from the European association of urologyR Vela Navarrete, J T Andersen, A Borowka, et al.
B-ENT|February 10, 2011
Antibiotic use and doctor visits are reduced after adenotonsillectomyN Lemkens, P Lemkens, T W Egondi, et al.
Cancer|September 1, 1990
Some limitations of the radioisotope bone scan in patients with metastatic prostatic cancer. A subanalysis of EORTC trial 30853. The EORTC Urological GroupP H Smith, A Bono, F Calais da Silva, et al.
Pageof 12